J&J's Janssen to close part of its vaccine division
Johnson & Johnson's Dutch business Janssen, which helped to develop the single-dose COVID-19 vaccine, will close almost its entire vaccine division, the company said on Wednesday, confirming Dutch ...
Kenvue completes separation from J&J ahead of S&P 500 inclusion
Kenvue announced that Wednesday, August 23, marked its first day as a fully independent company after it completed its separation from Johnson & Johnson (NYSE:JNJ). The consumer health company, who...
J&J Makes it Official: Kenvue Stock Swap Offer Was a Huge Hit With Shareholders
Johnson & Johnson investors were able to exchange less than a quarter of their shares for the consumer split off. The company will update financial guidance next week
Kenvue becomes ‘fully independent' after final separation from J&J
Kenvue Inc. KVUE, +3.67% kicks off life as a fully independent public company Wednesday after completing its separation from Johnson & Johnson JNJ, -0.79%, the company said in a release. J&J accept...
Kenvue stock price forecast: Is this JNJ spin-off a good buy?
Kenvue (NYSE: KVUE) stock price jumped by more than 3% on Tuesday as investors reacted to the oversubscription of an exchange offer for Johnson & Johnson (NYSE: JNJ). The stock jumped to a high of ...
J&J (JNJ) to Keep 9.5% Stake in Kenvue Post Share Exchange
J&J's (JNJ) offer to exchange its shares for the shares of Kenvue, its recently-separated consumer healthcare business, gets oversubscribed. The exchange ratio is 8.0324 for every share of J&J.
J&J spinoff Kenvue to join S&P 500 on Friday
Johnson & Johnson (NYSE:JNJ)'s consumer health spinoff Kenvue will replace Advance Auto Parts in the S&P 500 index effective Friday, August 25, the index announced. This comes after J&J offered to...
KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer
Kenvue (NYSE: KVUE ) stock is gaining modestly higher on Monday on the results of a share exchange with Johnson & Johnson (NYSE: JNJ ), from which Kenvue was spun off. Specifically, Johnson & Johns...
J&J says Kenvue tender offer was oversubscribed, expects 23.8% of tendered shares will be exchanged
Johnson & Johnson JNJ said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. KVUE tender offer that expired at midnight Friday. T...
J&J Exchange Offer for Kenvue Is Substantially Oversubscribed
Johnson & Johnson investors who elected to participate in the swap will see just 23.8% of their shares converted into Kenvue stock
Jim Cramer gives his view on what investors should do if they own J&J stock
Jim Cramer talks about the Johnson & Johnson exchange offer for shares of its split off consumer unit Kenvue. In the CNBC Investing Club's Monthly Meeting, Jim gave his view of what do to about J&J.
Here's Why it is a Good Time to Buy J&J's (JNJ) Stock Now
J&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma and MedTech units are likely to continue to drive sales growth in 2023.
The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023
The past few years have made many people realize the importance of building a retirement portfolio. Having dealt with a pandemic, layoffs, and inflation, investors realize the importance of having ...
Nearing Retirement? These Stocks Are as Safe as They Come
Johnson & Johnson has a fortress-like balance sheet. Coco-Cola generates lots of durable (and growing) cash flow.
A New Stock Is About to Join the S&P 500. Does History Show That Buying It Now Could Pay Off?
Johnson & Johnson spinoff Kenvue will soon be added to the S&P 500. History has shown that stocks often enjoy a boost after the announcement of their addition to the S&P 500.
Related Companies